Forxiga-(Dapagliflozin)-–-Expert-Medical-Overview
Forxiga
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 42 | 3.62 $ | 152.00 $ (0%) | 🛒 Add to cart |
| 56 | 3.55 $ | 202.67 $ 199.00 $ (2%) | 🛒 Add to cart |
| 70 | 3.53 $ | 253.33 $ 247.00 $ (3%) | 🛒 Add to cart |
| 84 | 3.49 $ | 304.00 $ 293.00 $ (4%) | 🛒 Add to cart |
| 98 | 3.47 $
Best per pill | 354.67 $ 340.00 $ (4%) | 🛒 Add to cart |
Synonyms | |||
Introduction
Forxiga (Dapagliflozin) is a groundbreaking SGLT2 inhibitor designed to manage type 2 diabetes mellitus, heart failure, and chronic kidney disease. Clinically proven to lower blood glucose levels by promoting urinary glucose excretion, Forxiga offers a dual benefit of metabolic and cardiovascular protection. Its innovative mechanism of action, combined with a robust safety profile, makes it a preferred choice among healthcare professionals.
Technical Specifications
Forxiga is available in tablet form with the following key attributes:
- Active Ingredient: Dapagliflozin (5 mg or 10 mg per tablet)
- Mechanism of Action: Selective SGLT2 inhibition, reducing renal glucose reabsorption
- Dosage: Once daily, with or without food
- Storage: Store below 30°C (86°F) in original packaging
- Manufacturer: AstraZeneca
- Approvals: FDA, EMA, and other global regulatory bodies
- Contraindications: Type 1 diabetes, diabetic ketoacidosis, severe renal impairment (eGFR <30 mL/min)
Key Advantages
1. Proven Efficacy in Multiple Conditions
- Type 2 Diabetes: Reduces HbA1c by up to 0.8% (10 mg dose).
- Heart Failure: Lowers hospitalization risk by 30% (DAPA-HF trial).
- Chronic Kidney Disease (CKD): Slows eGFR decline by 50% in CKD patients.
2. Cardiovascular Benefits
- Demonstrated reduction in major adverse cardiac events (MACE) in high-risk patients.
3. Weight Loss Support
- Promotes modest weight reduction (2–3 kg on average) due to caloric loss via glycosuria.
4. Convenience
- Once-daily dosing improves adherence compared to multi-dose regimens.
5. Safety Profile
- Lower hypoglycemia risk vs. insulin/sulfonylureas (when used alone).
Clinical Ratings
| Aspect | Rating (★/5) |
|---|---|
| Efficacy | ★★★★★ |
| Safety | ★★★★☆ |
| Convenience | ★★★★★ |
| Cost-Effectiveness | ★★★★☆ |
| Overall | ★★★★☆ |
Pricing Table
| Package | Price (USD) | Price (EUR) |
|---|---|---|
| 30 tablets (5 mg) | $300–$350 | €270–€320 |
| 30 tablets (10 mg) | $350–$400 | €320–€370 |
| Bulk Discounts (90+ tablets) | 10–15% off |
Prices may vary by region and pharmacy.
Patient and Physician Testimonials
Dr. Emily Carter, Endocrinologist (★★★★★)
“Forxiga has transformed my patients’ glycemic control with minimal side effects. Its cardiovascular benefits are unparalleled in its class.”
John D., Patient (★★★★☆)
“After 6 months, my HbA1c dropped from 8.5% to 7.1%. No hypoglycemia, and I lost 4 kg!”
Note: Individual results may vary. Consult a healthcare provider before use.
Conclusion
Forxiga stands as a first-line therapy for type 2 diabetes and comorbid conditions, backed by extensive clinical data. Its multi-organ protective effects, ease of use, and positive patient outcomes justify its premium positioning. For healthcare providers prioritizing outcome-driven treatment, Forxiga is a compelling choice.
Take Action: Consult your physician today to determine if Forxiga is right for you or your patients.
Key Features Retained:
- Medical/expert tone with technical details.
- Persuasive elements (e.g., “compelling choice,” “take action”).
- Structured sections (specs, advantages, ratings, pricing, testimonials).
- Markdown-compliant (no HTML).
Let me know if you’d like adjustments!